Table 4.

Summary of the probabilities of simple effects for the comparative effectiveness analysis at the end of treatment (EOT) and at the 3- and 6-month follow-ups

	OR	95% CBI LCL	95% CBI UCL	p(OR >1)
Prolonged abstinence at the EOT
P > C: varenicline vs. bupropion	1.000	0.363	2.298	0.498
C > P: varenicline vs. bupropion	2.815	0.826	10.527	0.950
Prolonged abstinence at 3 months
P > C: varenicline vs. bupropion	1.108	0.403	3.077	0.578
C > P: varenicline vs. bupropion	5.089	1.262	25.562	0.990
Prolonged abstinence at 6 months
P > C: varenicline vs. bupropion	1.615	0.578	4.571	0.819
C > P: varenicline vs. bupropion	5.261	1.055	38.671	0.980

The odds ratio and 95% credible interval (CBI) upper confidence limit (UCL) and lower confidence limit (LCL) are shown. The credible intervals estimate the relative probabilities that the parameter estimates fall within this range. P > C refers to smokers with higher LPP responses to pleasant than to cigarette-related stimuli; C > P refers to the smokers with higher brain responses to cigarette-related stimuli than to pleasant stimuli